首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

2008101

膝关节手术和人工关节重建疼痛管理药物市场：按药物、通路和地区划分

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, By Distribution Channel, By Geography

出版日期: 2026年03月12日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年，膝关节手术和人工关节重建术疼痛管理疗法的市场规模估计为48.764亿美元，预计到2033年将达到71.073亿美元。预计从2026年到2033年，该市场将以5.2%的复合年增长率成长。

报告范围		报告详情
基准年：	2025	2026年市场规模：	48.764亿美元
业绩数据週期：	2020-2024	预测期：	2026-2033
2026-2033年预测期间的复合年增长率：	5.20%	2033年市场规模预测：	71.073亿美元

有很多种药物可用于缓解疼痛，包括鸦片类药物、非类固醇消炎剂（NSAIDs）和乙酰胺酚。这些药物可以提高患者的舒适度，使其能够更早恢復活动，更快地从体力消耗中恢復，并加速膝关节手术或人工关节重建的康復。

此外，预计在预测期内，全膝关节置换术的数量将会增加，从而推动市场成长。

例如，根据美国国家生物技术资讯中心 (NCBI) 2017 年公布的数据，巴西每年进行的全膝关节置换术估计数量在 6 万至 7 万例之间。

市场动态

预计在预测期内，主要企业活性化研发力度，致力于开发和推出用于膝关节手术和人工关节重建的疼痛管理疗法，这将推动全球用于膝关节手术和人工关节重建的疼痛管理疗法市场成长。

例如，2021年5月，Alley Therapeutics——一家致力于研发超长效镇痛药的临床阶段生物技术公司，旨在革新术后疼痛管理和康復——公布了首个临床数据，证明其非阿片类镇痛药单次给药后即可持续两週。现有术后镇痛药物的疗效通常只能维持三天。此数据来自Alley公司首个候选药物ATX-101的1b/2a期临床试验，该药物用于治疗全膝关节关节重建（TKA）后的疼痛。

此外，药品核准的增加预计也将促进市场成长。例如，2020年3月，GlaxoSmithKline Plc宣布，美国食品药物管理局（FDA）已核准「Advil Dual Action（含对乙酰胺酚）」作为非处方止痛药上市。「Advil Dual Action」是一种领先的配方，结合了对乙酰胺酚和Ibuprofen这两种强效成分，它们均已获准用于非处方药，能够有效缓解多种症状，并透过不同的作用机制发挥作用。

本次调查的主要特点。

本报告以 2025 年为基准年，对全球膝关节手术和人工关节重建疼痛管理疗法市场进行了详细分析，并预测了其在预测期（2026-2033 年）内的复合年增长率（%）。
本报告指出了各个细分市场的潜在商机，并说明了该市场中具有吸引力的投资提案矩阵。
此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业所采取的竞争策略的关键见解。
本报告根据以下参数分析了全球膝关节手术和人工关节重建疼痛管理疗法市场的主要企业：公司概况、产品系列、主要亮点、财务表现和策略。
透过利用本报告中提出的见解，企业行销负责人和经营团队可以就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
透过各种策略矩阵，相关人员将能够更轻鬆地做出决策，这些矩阵用于分析膝关节手术和人工关节重建疼痛管理疗法的全球市场。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
南非
中非
北非

第七章竞争情势

衝突简介
- Pfizer Inc
- Allay Therapeutics
- Mallinckrodt
- Johnson &Johnson
- Zydus Cadila Healthcare Ltd.
- Novartis AG
- Purdue Pharma
- Delphis Pharmaceutical
- Taj Pharmaceuticals Limited
- GlaxoSmithKline plc
- AbbVie Inc
- Aurobindo Pharma

第八章

参考
调查方法

简介目录

Product Code: CMI4998

Knee Surgeries And Arthroplasty Pain Management Therapeutics Market is estimated to be valued at USD 4,876.4 Mn in 2026 and is expected to reach USD 7,107.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4,876.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 7,107.3 Mn

Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.

Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period

For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.

Market Dynamics

Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.

For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay's first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.

Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.

Key features of the study

This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market

Market Segmentation

By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc
- Allay Therapeutics
- Mallinckrodt
- Johnson & Johnson
- Zydus Cadila Healthcare Ltd.
- Novartis AG
- Purdue Pharma
- Delphis Pharmaceutical
- Taj Pharmaceuticals Limited
- GlaxoSmithKline plc
- AbbVie Inc.
- Aurobindo Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunity
Impact Analysis
Number of Total Knee Arthroplasty Surgeries
Key Developments
Regulatory Scenario
PEST Analysis
Pipeline Analysis
Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty

4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Acetaminophen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
COX-2 inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Non-steroidal Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
North America
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Region/Country, 2021-2033, (USD Mn)
South Africa
Central Africa
North Africa

7. Competitive Landscape

Competitive Snapshot
- Pfizer Inc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Allay Therapeutics
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Mallinckrodt
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Johnson & Johnson
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Zydus Cadila Healthcare Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Novartis AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Purdue Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Delphis Pharmaceutical
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Taj Pharmaceuticals Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- GlaxoSmithKline plc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- AbbVie Inc
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Aurobindo Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

膝关节手术和人工关节重建疼痛管理药物市场：按药物、通路和地区划分

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, By Distribution Channel, By Geography

市场动态